Skip to main content

Table 4 Mean and standard deviation of metabolites level in ACLF (baseline) compared to controls and follow−up

From: Reduced cortical thickness in patients with acute-on-chronic liver failure due to non-alcoholic etiology

Groups

Metabolites (mmol/kg)

NAA

MI

Glx

Control (a)

12.9 ± 1.30

2.60 ± 0.50

15.0 ± 2.50

Baseline (b)

10.9 ± 1.15

1.40 ± 0.69

22.5 ± 5.41

Follow−up (c)

11.2 ± 1.00

1.72 ± 0.41

18.1 ± 3.62

p-values

 a vs b

a − b = 0.001

a −b = 0.001

a − b = 0.001

 a vs c

a − c = 0.004

a − c = 0.001

a − c = 0.030

 b vs c

b − c = 0.424

b − c = 0.184

b − c = 0.024

  1. NAA N-acetyl aspartate, mI myo inositol, Glx glutamine/glutamate